WGS240719C20000
- 8.08
- 0.000.00%
GeneDx Holdings Newsroom
GeneDx Holdings(WGS.US) 10% Shareholder Sells US$2.46 Million in Common Stock
$GeneDx Holdings(WGS.US)$ 10% Shareholder OPKO HEALTH, INC. sold 89,082 shares of common stock on Jul 1, 2, 3, 2024 at an average price of $27.5845 for a total value of $2.46 million.Source: Announcem
Form 144(Amend) | GeneDx Holdings(WGS.US) 10% Stockholder Proposes to Sell 36.49 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 28, $GeneDx Holdings(WGS.US)$、$GENEDX HOLDINGS CORP C/WTS 22/07/2026 (TO PUR COM)(WGSWW.US)$ 10% Stockholder OPKO HEALTH, INC. intends to sell 1.37 million shares of its co
Form 144 | GeneDx Holdings(WGS.US) 10% Stockholder Proposes to Sell 6.96 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 28, $GeneDx Holdings(WGS.US)$、$GENEDX HOLDINGS CORP C/WTS 22/07/2026 (TO PUR COM)(WGSWW.US)$ 10% Stockholder OPKO HEALTH, INC. intends to sell 261.42K shares of its common
GeneDx Holdings Is Maintained at Buy by BTIG
GeneDx Holdings Is Maintained at Buy by BTIG
BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $35
BTIG analyst Mark Massaro maintains $GeneDx Holdings(WGS.US)$ with a buy rating, and adjusts the target price from $19 to $35.According to TipRanks data, the analyst has a success rate of 29.1% and a
GeneDx Hldgs Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/26/2024 28.44% BTIG $19 → $35 Maintains Buy 04/30/2024 -11.93% TD Cowen $14 → $24 Maintains Buy 04/30/2
Express News | GeneDx Holdings Corp : Btig Raises Target Price to $35 From $19
Market Participants Recognise GeneDx Holdings Corp.'s (NASDAQ:WGS) Revenues Pushing Shares 35% Higher
Despite an already strong run, GeneDx Holdings Corp. (NASDAQ:WGS) shares have been powering on, with a gain of 35% in the last thirty days. The last month tops off a massive increase of 293% in the
Insiders Buying GeneDx Holdings Might Wish They Invested More, Stock Gains 12%
Express News | GeneDx Expands Access To Rapid Whole Genome Sequencing In NICUs Through New Collaboration With Epic, Enhancing Integration With Health Systems Using Epic's EHR
Express News | GeneDx Announces Collaboration With Epic Aura to Expand Access to Rapid Whole Genome Sequencing (Rwgs) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
GeneDx Announces Collaboration With Epic Aura to Expand Access to Rapid Whole Genome Sequencing (RWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
-- New integration to streamline access for health systems and improve provider and patient journeys using Epic for electronic connections ---- Increases commercial footprint and focus on accelerating
Over $12M Bet On PBF Energy? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the s
GeneDx Holdings(WGS.US) 10% Shareholder Buys US$2.76 Million in Common Stock
$GeneDx Holdings(WGS.US)$ 10% Shareholder Casdin Capital, LLC purchased 130K shares of common stock on Jun 3, 4, 2024 at an average price of $21.2086 for a total value of $2.76 million. This transacti
Institutional Investors Have a Lot Riding on GeneDx Holdings Corp. (NASDAQ:WGS) With 47% Ownership
Key Insights Significantly high institutional ownership implies GeneDx Holdings' stock price is sensitive to their trading actions The top 4 shareholders own 50% of the company Insiders have sold
Express News | GeneDx Announced The First-of-its-kind Patient Access Program, Developed In Partnership With Leading Biopharma Companies, Which Aims To Increase Access To Exome Sequencing For Pediatric Epilepsy Patients
GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients
STAMFORD, Conn., June 05, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the first-of-its-kind patient acces
GeneDx Holdings(WGS.US) 10% Shareholder Buys US$842.6K in Common Stock
$GeneDx Holdings(WGS.US)$ 10% Shareholder Casdin Capital, LLC purchased 40,000 shares of common stock on May 29, 2024 at an average price of $21.0651 for a total value of $842.6K. This transaction inv
Over $4M Bet On ProFrac Holding? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stoc
GeneDx Holdings(WGS.US) 10% Shareholder Buys US$3.42 Million in Common Stock
$GeneDx Holdings(WGS.US)$ 10% Shareholder Casdin Capital, LLC purchased 170K shares of common stock on May 23, 24, 28, 2024 at an average price of $20.147 for a total value of $3.42 million. This tran